Physician Profile
Mary Mulcahy, MD
Unclaimed ProfileAbout Dr. Mulcahy
Mary Mulcahy, MD is a healthcare provider in Chicago, IL specializing in medical oncology. Mary trained at Un of California, Irvine, College of Medicine, graduating in 1993. Medicare claims data shows Mary provided 142,670 services to 1,265 patients. The services billed most often include injection, daratumumab, 10 mg and hyaluronidase-fihj, injection, oxaliplatin, 0.5 mg, and injection, teclistamab-cqyv, 0.5 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
Education & Training
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (312) 695-0990
- Email not available
Practice Locations
675 N SAINT CLAIR ST GALTER 21-100
Chicago, IL 60611
Conditions Commonly Evaluated or Treated
Within Medical Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Abdominal cancer
Blood cancer
Blood disorders
Cancer complications
Chest cancer
Complications
Digestive cancer
Digestive cancers
Endocrine cancer
Endocrine cancers
Eye cancer
General oncology
Genetic risk
Gynecologic cancer
Gynecologic cancers
Head and neck
Head and neck cancer
Metastatic cancer
Metastatic disease
Neurologic cancers
Sarcomas
Skin cancer
Symptom evaluation
Thoracic cancers
Treatment side effects
Urologic cancer
Urologic cancers
Procedures & services
Most searched procedures
Cancer treatment care
Complication management
Consultations
- Cancer survivorship care
- Integrative oncology consultation
- Post-cancer surveillance scan review
- Pre-Surgery Chemotherapy Consultation
- Preventative Chemotherapy Consultation
- Radiopharmaceutical therapy consultation
- Second Opinion For Cancer
- Stem cell transplant consultation
- Tumor Board Case Review
Diagnostic testing
Diagnostics
- Bone Marrow Biopsy
- Cancer Genetic Testing
- Pathology second opinion for cancer
- Tumor Biomarker Testing
Infusions
- Bone Strengthening Infusion
- Iron Infusion
- IV hydration for cancer patients
- Neurologic infusion treatment
Injections
Medication management
Patient education
Port and line care
Procedures
Specialized treatments
- Bladder instillation therapy
- Heated Chemotherapy Consultation
- Hepatic Artery Pump Chemotherapy Consultation
Specialty treatments
- Bone Strengthening Injections For Cancer
- CAR-T Therapy
- Chemo allergy desensitization
- Clinical Trial Screening
- Hormone Therapy For Cancer
- Spinal chemo injection
Supportive care
- Advance Care Planning For Cancer
- Cancer nutrition counseling
- Cancer pain management
- Cancer Rehabilitation Evaluation
- Cancer weight loss management
- Chemo brain treatment
- Chemo nausea treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hospice care consultation
- Lymphedema evaluation
- Palliative cancer care
Treatment side effects
Vascular access
Procedures Most Often Billed to Medicare
142,670 services · 1,265 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection of additional new drug or substance into vein | Treatment | 96375 |
464 | More often than most peers in Medical Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
367 | More often than most peers in Medical Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Treatment | 96366 |
334 | More than most peers in Medical Oncology |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
27,180 | More than most peers in Medical Oncology |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
15,284 | More often than most peers in Medical Oncology |
| Injection, teclistamab-cqyv, 0.5 mg | Drug given | J9380 |
13,770 | Too few peers to compare |
| Injection, ferric carboxymaltose, 1 mg | Drug given | J1439 |
13,500 | Less often than most peers in Medical Oncology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
12,600 | More often than most peers in Medical Oncology |
| Injection, methylprednisolone sodium succinate, 5 mg | Drug given | J2919 |
11,384 | More than most peers in Medical Oncology |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Drug given | J1569 |
9,740 | More often than most peers in Medical Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other oncologists at this location 2
Same specialty, same street address — most likely the same department or group.
Related specialists at this location 3
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 25 related providers in 4 groups
Other oncologists in Chicago 7
Same specialty, same city.
Trained at Un of California, Irvine, College of Medicine 2
Other providers in the same specialty who trained at the same institution.
Class of 1993 at Un of California, Irvine, College of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Injection of additional new drug or substance into vein 8
Providers in IL who bill this service to Medicare most often.
Common questions
What does Dr. Mulcahy specialize in?
Dr. Mulcahy is an oncologist in Chicago, IL. That is the designation recorded for this NPI in the federal registry, where it is listed as “Medical Oncology”.
NPI registry
Where is Dr. Mulcahy located?
Dr. Mulcahy is listed at 675 N Saint Clair St Galter 21-100, Chicago, IL 60611. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Dr. Mulcahy's phone number?
The number on file is (312) 695-0990. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is the NPI for Dr. Mulcahy?
Dr. Mulcahy's National Provider Identifier is 1306870837. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Dr. Mulcahy go to medical school?
Dr. Mulcahy attended Un of California, Irvine, College of Medicine, graduating in 1993. This comes from the CMS National Downloadable File.
CMS public data
How much experience does Dr. Mulcahy have?
Dr. Mulcahy has 33 years experience. Calculated from a graduation year of 1993, reported in the CMS National Downloadable File.
CMS public data
What does Dr. Mulcahy do most often?
According to Medicare billing data, Dr. Mulcahy provides treatments such as injection of additional new drug or substance into vein and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is Dr. Mulcahy's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Mulcahy. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.